ENABLING REGULATION-COMPLIANT GENETIC SAMPLE TRANSFERS FOR RARE DISEASE DIAGNOSTICS

Understanding the underlying genetic mutations or variations is crucial for accurate diagnosis and personalized treatment of rare diseases. Therefore, genetic diagnostic programs hold paramount importance in the rare disease field.

Trispera Pharma Solutions is fully aware of the critical role that genetic diagnostics play in the rare disease landscape and is committed to facilitating the transfer of biological materials to genetic centers abroad in order to advance research and diagnostics.

We organize the transfer of biological materials from centers involved in clinical or epidemiological studies, or diagnostic programs, to laboratories abroad, with the approval of the relevant ethics committees and the Ministry of Health of Türkiye.

According to the regulation published in the Official Gazette on April 10, 2016, only licensed medical laboratories are authorized to send samples abroad for testing purposes. Trispera Pharma Solutions coordinates nationwide diagnostic services through these licensed medical laboratories on behalf of sponsors and/or investigators.